The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain
Top Cited Papers
- 8 June 2010
- journal article
- research article
- Published by Wiley in Angewandte Chemie-International Edition
- Vol. 49 (37), 6545-6548
- https://doi.org/10.1002/anie.201000620
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Treatment of painful neuropathyCurrent Opinion in Neurology, 2007
- Modulation of pain transmission by G-protein-coupled receptorsPharmacology & Therapeutics, 2007
- Are α9α10 Nicotinic Acetylcholine Receptors a Pain Target for α-Conotoxins?Molecular Pharmacology, 2007
- Oral absorption and in vivo biodistribution of α-conotoxin MII and a lipidic analogueBiochemical and Biophysical Research Communications, 2007
- Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptorsProceedings of the National Academy of Sciences, 2006
- α-Selenoconotoxins, a New Class of Potent α7 Neuronal Nicotinic Receptor AntagonistsJournal of Biological Chemistry, 2006
- Structure-activity relationships of alpha-conotoxins targeting neuronal nicotinic acetylcholine receptorsEuropean Journal of Biochemistry, 2004
- A Novel α-Conotoxin Identified by Gene Sequencing Is Active in Suppressing the Vascular Response to Selective Stimulation of Sensory Nerves in VivoBiochemistry, 2003
- Crystal Structure at 1.1 Å Resolution of α-Conotoxin PnIB: Comparison with α-Conotoxins PnIA and GIBiochemistry, 1997
- In situ neutralization in Boc‐chemistry solid phase peptide synthesisInternational Journal of Peptide and Protein Research, 1992